Man Group Portfolio holdings
AUM
$46.3B
1-Year Return
20.09%
This Quarter Return
+9.91%
1 Year Return
+20.09%
3 Year Return
+87.95%
5 Year Return
+152.77%
10 Year Return
–
AUM
$37.2B
AUM Growth
+$2.4B
(+6.9%)
Cap. Flow
-$1.85B
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
2,212
New
291
Increased
869
Reduced
680
Closed
223
Top Buys
| 1 |
Blackrock
BLK
|
$181M |
| 2 |
Equinix
EQIX
|
$152M |
| 3 |
Merck
MRK
|
$140M |
| 4 |
State Street
STT
|
$126M |
| 5 |
Dynatrace
DT
|
$125M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$295M |
| 2 |
TSMC
TSM
|
$254M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$223M |
| 4 |
Salesforce
CRM
|
$160M |
| 5 |
Invesco QQQ Trust
QQQ
|
$153M |
Sector Composition
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 13.3% |
| 3 | Financials | 12.82% |
| 4 | Healthcare | 12.28% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Brown-Forman Class B
BF.B
$13.7B
| $227K | ﹤0.01% |
4,393
-861
| -16% | -$44.4K |
|
1752
National Research Corp
NRC
$355M
| $227K | ﹤0.01% |
5,725
-17,967
| -76% | -$712K |
|
1753
Greenwich LifeSciences
GLSI
$149M
| $227K | ﹤0.01% |
+11,365
| New | +$227K |
|
|
MTTR
1754
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $224K | ﹤0.01% |
+99,150
| New | +$224K |
|
1755
First Business Financial Services
FBIZ
$433M
| $223K | ﹤0.01% |
+5,935
| New | +$223K |
|
|
FSP
1756
Franklin Street Properties
FSP
$174M
| $221K | ﹤0.01% |
97,343
-93,496
| -49% | -$212K |
|
1757
Extreme Networks
EXTR
$2.87B
| $219K | ﹤0.01% |
18,987
-1,569,120
| -99% | -$18.1M |
|
|
ACCS
1758
ACCESS Newswire Inc.
ACCS
$42.2M
| $218K | ﹤0.01% |
16,837
+3,777
| +29% | +$48.8K |
|
1759
Hurco Companies Inc
HURC
$117M
| $216K | ﹤0.01% |
+10,739
| New | +$216K |
|
|
RDUS
1760
DELISTED
Radius Recycling
RDUS
| $216K | ﹤0.01% |
+10,219
| New | +$216K |
|
1761
TransAlta
TAC
$3.64B
| $215K | ﹤0.01% |
33,500
-148,100
| -82% | -$951K |
|
1762
SI-BONE Inc
SIBN
$703M
| $214K | ﹤0.01% |
+13,063
| New | +$214K |
|
1763
Zedge
ZDGE
$41.4M
| $212K | ﹤0.01% |
76,441
+25,214
| +49% | +$69.8K |
|
1764
Alamo Group
ALG
$2.53B
| $211K | ﹤0.01% |
+924
| New | +$211K |
|
1765
Ramaco Resources Class B
METCB
$1.05B
| $210K | ﹤0.01% |
+17,119
| New | +$210K |
|
1766
Gentherm
THRM
$1.1B
| $209K | ﹤0.01% |
+3,637
| New | +$209K |
|
1767
Commercial Vehicle Group
CVGI
$68.1M
| $205K | ﹤0.01% |
31,949
-5,262
| -14% | -$33.8K |
|
1768
Equity Lifestyle Properties
ELS
$12B
| $204K | ﹤0.01% |
3,175
| – | – |
|
|
CTV
1769
DELISTED
Innovid Corp.
CTV
| $203K | ﹤0.01% |
+81,630
| New | +$203K |
|
1770
V2X
VVX
$1.79B
| $202K | ﹤0.01% |
+4,331
| New | +$202K |
|
1771
Moog
MOG.A
$6.17B
| $201K | ﹤0.01% |
1,261
-2,280
| -64% | -$364K |
|
|
VERV
1772
DELISTED
Verve Therapeutics
VERV
| $201K | ﹤0.01% |
15,135
+3,717
| +33% | +$49.4K |
|
1773
inTEST
INTT
$90.7M
| $198K | ﹤0.01% |
14,981
+2,539
| +20% | +$33.6K |
|
1774
Vanda Pharmaceuticals
VNDA
$272M
| $196K | ﹤0.01% |
+47,730
| New | +$196K |
|
1775
Ocular Therapeutix
OCUL
$2.37B
| $196K | ﹤0.01% |
+21,543
| New | +$196K |
|